Order Your Copy!
Preface
About This Treatment Guide
cancers of the head and neck regionCh 1 Head and neck tumors Ch 2 Thyroid and parathyroid cancers
LUNG CANCERCh 3 Non-small-cell lung cancer Ch 4 Small-cell lung cancer, mesothelioma, and thymoma
Breast cancerCh 5 Breast cancer overview Risk factors, screening, genetic testing, and prevention Ch 6 Stages 0 and I breast cancer Ch 7 Stage II breast cancer Ch 8 Stages III and IV breast cancer
GASTROINTESTINAL CANCERSCh 9 Esophageal cancer Ch 10 Gastric cancer Ch 11 Pancreatic, neuroendocrine GI, and adrenal cancers Ch 12 Liver, gallbladder, and biliary tract cancers Ch 13 Colon, rectal, and anal cancers
GENITOURINARY MALIGNANCIESCh 14 Prostate cancer Ch 15 Testicular cancer Ch 16 Urothelial and kidney cancers
GYNECOLOGIC MALIGNANCIESCh 17 Cervical cancer Ch 18 Uterine corpus tumors Ch 19 Ovarian cancer
SKIN CANCERSCh 20 Melanoma and other skin cancers
SarcomasCh 21 Bone sarcomas Ch 22 Soft-tissue sarcomas
Brain TUMORSCh 23 Primary and metastatic brain tumors
other SOLID TUMORSCh 24 AIDS-related malignancies Ch 25 Carcinoma of an unknown primary site
hematologic malignanciesCh 26 Hodgkin lymphoma Ch 27 Non-Hodgkin lymphoma Ch 28 Multiple myeloma and other plasma cell dyscrasias Ch 29 Acute leukemias Ch 30 Chronic myeloid leukemia Ch 31 Chronic lymphocytic leukemia Ch 32 Myelodysplastic syndromes Ch 33 Hematopoietic cell transplantation
Palliative and SUPPORTIVE CARECh 34 Pain management Ch 35 Management of nausea and vomiting Ch 36 Depression, anxiety, and delirium Ch 37 Fatigue and dyspnea Ch 38 Anorexia and cachexia
COMPLICATIONSCh 39 Oncologic emergencies and paraneoplastic syndromes Ch 40 Infectious complications Ch 41 Fluid complications
Color AtlasesColor atlas 1: The ABCDEs of moles and melanomas Color atlas 3: Dermatologic toxicities associated with targeted therapies APPENDICESAppendix 1: Response evaluation criteria and performance scales Appendix 2: Cancer information on the Internet Appendix 3: Cancer drugs and indications newly approved by the US Food and Drug Administration Appendix 4: Chemotherapeutic agents and their uses, dosages, and toxicities Emiliano Calvo, MD, PhD and Antonio Calles, MD
Table of Contents
Chapter 1: Head and Neck Tumors Chapter 2: Thyroid and Parathyroid Cancers Chapter 3: Non-Small-Cell Lung Cancer Chapter 4: Small-Cell Lung Cancer, Mesothelioma, and Thymoma Chapter 5: Breast Cancer Overview Chapter 6: Stages 0 and I breast cancer Chapter 7: Stage II breast cancer Chapter 8: Stages III and IV breast cancer Chapter 11: Pancreatic, neuroendocrine GI, and adrenal cancers Chapter 12: Liver, gallbladder, and biliary tract cancers Chapter 13: Colon, rectal, and anal cancers Chapter 16: Urothelial and kidney cancers Chapter 18: Uterine corpus tumors Chapter 20: Melanoma and other skin cancers Chapter 22: Soft-tissue sarcomas Chapter 23: Primary and metastatic brain tumors Chapter 24: AIDS-related malignancies Chapter 25: Carcinoma of an unknown primary site Chapter 27: Non-Hodgkin lymphoma Chapter 28: Multiple myeloma and other plasma cell dyscrasias Chapter 30: Chronic myeloid leukemia Chapter 31: Chronic lymphocytic leukemia Chapter 32: Myelodysplastic syndromes Chapter 33: Hematopoietic cell transplantation Chapter 35: Management of nausea and vomiting Chapter 36: Depression, anxiety, and delirium Chapter 37: Fatigue and dyspnea Chapter 38: Anorexia and cachexia Chapter 39: Oncologic emergencies and paraneoplastic syndromes Chapter 40: Infectious complications Chapter 41: Fluid complications Color atlas The ABCDEs of moles and melanomas Color atlas 3: Dermatologic toxicities associated with targeted therapies Appendix 1: Response Evaluation Criteria and Performance Scales Appendix 2: Cancer Information on the Internet Appendix 3: Cancer Drugs and Indications Newly Approved by the US Food and Drug Administration Appendix 4: Chemotherapeutic Agents Their Uses, Dosages, and Toxicites |
|||||